Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.24.2.u1
CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 17 $ 1,368,979 $ (153) $ (1,382,459) $ (13,616)
Balance (in shares) at Dec. 31, 2022 17,339,816        
Increase (Decrease) in Stockholders' Equity          
Net loss       (13,536) (13,536)
Net change in unrealized gain (loss) on short-term investments     126   126
Issuance of common stock upon exercise of options   1     1
Issuance of common stock upon exercise of options (in shares) 95        
Issuance of common stock upon vesting of restricted stock units (RSUs) (in shares) 26,625        
Stock-based compensation expense   2,768     2,768
Balance at Mar. 31, 2023 $ 17 1,371,748 (27) (1,395,995) (24,257)
Balance (in shares) at Mar. 31, 2023 17,366,536        
Balance at Dec. 31, 2022 $ 17 1,368,979 (153) (1,382,459) (13,616)
Balance (in shares) at Dec. 31, 2022 17,339,816        
Increase (Decrease) in Stockholders' Equity          
Net loss         (20,136)
Net change in unrealized gain (loss) on short-term investments         128
Balance at Jun. 30, 2023 $ 17 1,374,488 (25) (1,402,595) (28,115)
Balance (in shares) at Jun. 30, 2023 17,435,790        
Balance at Mar. 31, 2023 $ 17 1,371,748 (27) (1,395,995) (24,257)
Balance (in shares) at Mar. 31, 2023 17,366,536        
Increase (Decrease) in Stockholders' Equity          
Net loss       (6,600) (6,600)
Net change in unrealized gain (loss) on short-term investments     2   2
Issuance of common stock upon exercise of options   554     554
Issuance of common stock upon exercise of options (in shares) 52,379        
Issuance of common stock upon vesting of restricted stock units (RSUs) (in shares) 16,875        
Stock-based compensation expense   2,186     2,186
Balance at Jun. 30, 2023 $ 17 1,374,488 (25) (1,402,595) (28,115)
Balance (in shares) at Jun. 30, 2023 17,435,790        
Balance at Dec. 31, 2023 $ 17 1,378,881 8 (1,407,550) (28,644)
Balance (in shares) at Dec. 31, 2023 17,482,513        
Increase (Decrease) in Stockholders' Equity          
Net loss       (8,247) (8,247)
Net change in unrealized gain (loss) on short-term investments     (13)   (13)
Issuance of common stock upon exercise of options   89     89
Issuance of common stock upon exercise of options (in shares) 9,066        
Issuance of common stock upon vesting of restricted stock units (RSUs) (in shares) 48,658        
Stock-based compensation expense   5,144     5,144
Balance at Mar. 31, 2024 $ 17 1,384,114 (5) (1,415,797) (31,671)
Balance (in shares) at Mar. 31, 2024 17,540,237        
Balance at Dec. 31, 2023 $ 17 1,378,881 8 (1,407,550) (28,644)
Balance (in shares) at Dec. 31, 2023 17,482,513        
Increase (Decrease) in Stockholders' Equity          
Net loss         (9,277)
Net change in unrealized gain (loss) on short-term investments         (17)
Balance at Jun. 30, 2024 $ 17 1,386,905 (9) (1,416,827) (29,914)
Balance (in shares) at Jun. 30, 2024 17,594,117        
Balance at Mar. 31, 2024 $ 17 1,384,114 (5) (1,415,797) (31,671)
Balance (in shares) at Mar. 31, 2024 17,540,237        
Increase (Decrease) in Stockholders' Equity          
Net loss       (1,030) (1,030)
Net change in unrealized gain (loss) on short-term investments     (4)   (4)
Issuance of common stock upon exercise of options   252     252
Issuance of common stock upon exercise of options (in shares) 36,130        
Issuance of common stock upon vesting of restricted stock units (RSUs) (in shares) 17,750        
Stock-based compensation expense   2,539     2,539
Balance at Jun. 30, 2024 $ 17 $ 1,386,905 $ (9) $ (1,416,827) $ (29,914)
Balance (in shares) at Jun. 30, 2024 17,594,117